Baingana F et al (2015) Global research challenges and opportunities for mental health and substance-use disorders. Nature 527(7578):S172–S177. https://doi.org/10.1038/nature16032

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang JP et al (2013) Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol 16(6):1205–18. https://doi.org/10.1017/S1461145712001277

Article  CAS  PubMed  Google Scholar 

Correll CU (2010) From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics. Eur Psychiatry 25(Suppl 2):S12-21. https://doi.org/10.1016/S0924-9338(10)71701-6

Article  PubMed  Google Scholar 

Carney AC (2013) Efficacy of quetiapine off-label uses: data synthesis. J Psychosoc Nurs Ment Health Serv 51(8):11–18. https://doi.org/10.3928/02793695-20130709-01

Article  PubMed  Google Scholar 

in Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care. 2014: London

Yatham LN et al (2018) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 20(2):97–170. https://doi.org/10.1111/bdi.12609

Article  PubMed  PubMed Central  Google Scholar 

Sakurai H et al (2020) Pharmacological management of bipolar disorder: Japanese expert consensus. Bipolar Disord 22(8):822–830. https://doi.org/10.1111/bdi.12959

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Z et al., (2023) Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study. Pharmaceuticals (Basel), 16(2). https://doi.org/10.3390/ph16020287

Lin CY et al (2023) Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials. Eur Neuropsychopharmacol 67:22–36. https://doi.org/10.1016/j.euroneuro.2022.11.008

Article  CAS  PubMed  Google Scholar 

Wang J et al (2021) Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey. BMC Psychiatry 21(1):375. https://doi.org/10.1186/s12888-021-03374-0

Article  PubMed  PubMed Central  Google Scholar 

De Hert M et al (2011) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8(2):114–126. https://doi.org/10.1038/nrendo.2011.156

Article  CAS  PubMed  Google Scholar 

Ray WA et al (2009) Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360(3):225–235. https://doi.org/10.1056/NEJMoa0806994

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu CS et al (2018) Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study. J Affect Disord 226:77–84. https://doi.org/10.1016/j.jad.2017.09.020

Article  PubMed  Google Scholar 

Berge J et al (2022) Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality. J Psychiatr Res 149:352–358. https://doi.org/10.1016/j.jpsychires.2021.11.023

Article  PubMed  Google Scholar 

Stubbs B et al (2015) The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr Scand 132(2):144–157. https://doi.org/10.1111/acps.12439

Article  CAS  PubMed  Google Scholar 

Brown S et al (2010) Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 196(2):116–121. https://doi.org/10.1192/bjp.bp.109.067512

Article  PubMed  PubMed Central  Google Scholar 

Umpierrez GE, Kitabchi AE (2003) Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol 2(2):95–108

PubMed  Google Scholar 

Garrett CJ et al (2019) Recurrent diabetic ketoacidosis and a brief history of brittle diabetes research: contemporary and past evidence in diabetic ketoacidosis research including mortality, mental health and prevention. Diabet Med 36(11):1329–1335

CAS  PubMed  Google Scholar 

English P, Williams G (2004) Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Postgrad Med J 80(943):253–261. https://doi.org/10.1111/dme.14109

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakaeda T et al (2013) Data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci 10(7):796–803. https://doi.org/10.7150/ijms.6048

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, X., H. Yang, and Z. An, (2024) Tacrolimus related diabetic ketoacidosis and hyperglycaemic hyperosmolar nonketotic syndrome: an observational, retrospective, pharmacovigilance study. Expert Opin Drug Saf, 1–6. https://doi.org/10.1080/14740338.2024.2393278.

Sennesael AL, Henrard S, Spinewine A (2018) Drug Interactions With Non-Vitamin K Oral Anticoagulants. JAMA 319(8):829. https://doi.org/10.1001/jama.2017.20834

Article  PubMed  Google Scholar 

Vogel A et al (2022) Hepatocellular carcinoma. Lancet 400(10360):1345–1362

CAS  PubMed  Google Scholar 

van Puijenbroek EP et al (2002) A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11(1):3–10. https://doi.org/10.1002/pds.668

Article  CAS  PubMed  Google Scholar 

Wilson AM, Thabane L, Holbrook A (2004) Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 57(2):127–134. https://doi.org/10.1046/j.1365-2125.2003.01968.x

Article  PubMed  PubMed Central  Google Scholar 

Evans SJ, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10(6):483–486. https://doi.org/10.1002/pds.677

Article  CAS  PubMed  Google Scholar 

Hauben M, Zhou X (2003) Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf 26(3):159–186. https://doi.org/10.2165/00002018-200326030-00003

Article  PubMed  Google Scholar 

Chen JJ et al (2022) Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system. Int J Clin Pharm 44(6):1351–1360. https://doi.org/10.1007/s11096-022-01472-x

Article  CAS  PubMed  Google Scholar 

Gummin DD et al (2019) 2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila) 57(12):1220–1413. https://doi.org/10.1080/15563650.2019.1677022

Article  CAS  PubMed  Google Scholar 

Deng ZZ et al (2024) Data mining of adverse drug enent signals for quetiapine based on FAERS database. Central South Pharmacy 22(08):2248–2254. https://doi.org/10.7539/j.issn.1672-2981.2024.08.048

Article  Google Scholar 

Kitabchi AE et al (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32(7):1335–1343. https://doi.org/10.2337/dc09-9032

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calimag APP et al (2023) Diabetic ketoacidosis. Dis Mon 69(3):101418. https://doi.org/10.1016/j.disamonth.2022.101418

Article  PubMed  Google Scholar 

Desai D et al (2018) Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwid